Clinical Study
Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus
Table 2
Comparison of responders and nonresponders at 6 months after rituximab administration ().
|